HAR6118: Utility and Patient-reported Outcomes Data in HTA (online)
The module explores the assessment and generation of patient reported outcomes for use in international health technology assessment, the quality adjusted life year (QALY) model and its weaknesses, and alternative methods of valuing benefits. The approaches used to generate outcomes and other utility data will be explored in relation to current practice guidelines of reimbursement and other agencies in different countries.
This module aims to explore in detail specialist topics related to the generation of utilities and other outcome data for use in international health technology assessment.
By the end of the module, students will be able to:
- Identify and critically appraise a range of different approaches used to generate utility and other outcomes data for use in health technology assessment;
- Critically evaluate the strengths and weaknesses of the QALY model and alternative approaches;
- Critically evaluate different methods used to generate utility and other outcomes data, in relation to current practice guidelines, different contexts and different countries.
- Bespoke online methods will be used to present the principles behind alternative approaches used to generate outcomes and other utility data for use in health technology assessment and to direct students to the appropriate methodological literature, and to assess the relative strengths and weaknesses of QALY and other models
- Exercises based around a selection of the different approaches will be used to help to develop a critical understanding of the different approaches used to generate utility and other outcomes data and their appropriateness in different contexts.
- Guided independent study will deepen awareness, understanding and evaluation of the alternative approaches used to generate utility and other outcomes data for use in international health technology assessment.
|Assignment (4,000 words)||100%|
Assessment will comprise of two 2000-word essays that cover:
1. Critical evaluation of methods used to generate utility data for international health technology assessment
2. Critical examination of whether a broader perspective should be taken in the assessment of new interventions and treatments
The pass mark is 50%.